Incannex Healthcare Limit... (IXHL)
1.72
-0.06 (-3.37%)
At close: Jan 14, 2025, 1:45 PM
1.77
2.91%
After-hours Jan 14, 2025, 01:45 PM EST
undefined% (undefined)
| Bid | 1.71 |
| Market Cap | 30.35M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.36 |
| PE Ratio (ttm) | -1.26 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.01 |
| Volume | 19,908 |
| Avg. Volume (20D) | 32,773 |
| Open | 1.74 |
| Previous Close | 1.78 |
| Day's Range | 1.72 - 1.79 |
| 52-Week Range | 1.50 - 8.47 |
| Beta | undefined |
About IXHL
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of...
Sector Healthcare
IPO Date Mar 2, 2022
Employees 9
Stock Exchange NASDAQ
Ticker Symbol IXHL
Website https://www.incannex.com.au
3 months ago ·
Source
-15.58%
Incannex Healthcare shares are trading lower after...
Unlock content with
Pro Subscription
10 months ago ·
Source
+48.58%
Incannex shares are trading higher after the company announced its Psi-GAD1 trial met its primary endpoint.
1 month ago · newsfilecorp.com
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025Dallas, Texas--(Newsfile Corp. - December 2, 2024) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). During 1Q 2...